These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 8358726

  • 1. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
    Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG.
    Cancer Res; 1993 Sep 01; 53(17):3976-85. PubMed ID: 8358726
    [Abstract] [Full Text] [Related]

  • 2. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note.
    Kaufmann SH.
    Cancer Res; 1989 Nov 01; 49(21):5870-8. PubMed ID: 2790800
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

  • 4. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
    Stiewe T, Parssanedjad K, Esche H, Opalka B, Pützer BM.
    Cancer Res; 2000 Jul 15; 60(14):3957-64. PubMed ID: 10919674
    [Abstract] [Full Text] [Related]

  • 5. Characterization of antibodies specific for the caspase cleavage site on poly(ADP-ribose) polymerase: specific detection of apoptotic fragments and mapping of the necrotic fragments of poly(ADP-ribose) polymerase.
    Sallmann FR, Bourassa S, Saint-Cyr J, Poirier GG.
    Biochem Cell Biol; 1997 Jul 15; 75(4):451-6. PubMed ID: 9493968
    [Abstract] [Full Text] [Related]

  • 6. Functional interactions of p53 with poly(ADP-ribose) polymerase (PARP) during apoptosis following DNA damage: covalent poly(ADP-ribosyl)ation of p53 by exogenous PARP and noncovalent binding of p53 to the M(r) 85,000 proteolytic fragment.
    Kumari SR, Mendoza-Alvarez H, Alvarez-Gonzalez R.
    Cancer Res; 1998 Nov 15; 58(22):5075-8. PubMed ID: 9823314
    [Abstract] [Full Text] [Related]

  • 7. Intact cell evidence for the early synthesis, and subsequent late apopain-mediated suppression, of poly(ADP-ribose) during apoptosis.
    Rosenthal DS, Ding R, Simbulan-Rosenthal CM, Vaillancourt JP, Nicholson DW, Smulson M.
    Exp Cell Res; 1997 May 01; 232(2):313-21. PubMed ID: 9168807
    [Abstract] [Full Text] [Related]

  • 8. Radiation-induced apoptosis of Ewing's sarcoma cells: DNA fragmentation and proteolysis of poly(ADP-ribose) polymerase.
    Soldatenkov VA, Prasad S, Notario V, Dritschilo A.
    Cancer Res; 1995 Oct 01; 55(19):4240-2. PubMed ID: 7671228
    [Abstract] [Full Text] [Related]

  • 9. Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl.
    Mc Gee MM, Campiani G, Ramunno A, Fattorusso C, Nacci V, Lawler M, Williams DC, Zisterer DM.
    J Pharmacol Exp Ther; 2001 Jan 01; 296(1):31-40. PubMed ID: 11123359
    [Abstract] [Full Text] [Related]

  • 10. Characterization of interior cleavage of retinoblastoma protein in apoptosis.
    Fattman CL, An B, Dou QP.
    J Cell Biochem; 1997 Dec 01; 67(3):399-408. PubMed ID: 9361194
    [Abstract] [Full Text] [Related]

  • 11. The altered apoptotic pathways in cisplatin and etoposide-resistant melanoma cells are drug specific.
    Kissel CK, Schadendorf D, Röckmann H.
    Melanoma Res; 2006 Dec 01; 16(6):527-35. PubMed ID: 17119454
    [Abstract] [Full Text] [Related]

  • 12. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
    Pogrebniak A, Schemainda I, Pelka-Fleischer R, Nüssler V, Hasmann M.
    Eur J Med Res; 2003 Oct 22; 8(10):438-50. PubMed ID: 14594650
    [Abstract] [Full Text] [Related]

  • 13. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW, Chong SY, Kim JY, Eom JI, Jeung HK, Maeng HY, Lee ST, Min YH.
    Clin Cancer Res; 2003 Oct 15; 9(13):5018-27. PubMed ID: 14581377
    [Abstract] [Full Text] [Related]

  • 14. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN.
    Cancer Res; 1998 Aug 01; 58(15):3202-8. PubMed ID: 9699642
    [Abstract] [Full Text] [Related]

  • 15. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
    Kuo ML, Shen SC, Yang CH, Chuang SE, Cheng AL, Huang TS.
    Oncogene; 1998 Oct 29; 17(17):2225-34. PubMed ID: 9811453
    [Abstract] [Full Text] [Related]

  • 16. Poly(ADP-ribose) polymerase cleavage during apoptosis: when and where?
    Soldani C, Lazzè MC, Bottone MG, Tognon G, Biggiogera M, Pellicciari CE, Scovassi AI.
    Exp Cell Res; 2001 Oct 01; 269(2):193-201. PubMed ID: 11570811
    [Abstract] [Full Text] [Related]

  • 17. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
    Gorczyca W, Gong J, Ardelt B, Traganos F, Darzynkiewicz Z.
    Cancer Res; 1993 Jul 01; 53(13):3186-92. PubMed ID: 8319228
    [Abstract] [Full Text] [Related]

  • 18. Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death.
    Robertson NM, Zangrilli J, Fernandes-Alnemri T, Friesen PD, Litwack G, Alnemri ES.
    Cancer Res; 1997 Jan 01; 57(1):43-7. PubMed ID: 8988038
    [Abstract] [Full Text] [Related]

  • 19. Effect of inhibitors of poly(ADP-ribose) polymerase on the induction of GRP78 and subsequent development of resistance to etoposide.
    Chatterjee S, Cheng MF, Berger RB, Berger SJ, Berger NA.
    Cancer Res; 1995 Feb 15; 55(4):868-73. PubMed ID: 7850801
    [Abstract] [Full Text] [Related]

  • 20. Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells.
    Beere HM, Chresta CM, Hickman JA.
    Mol Pharmacol; 1996 May 15; 49(5):842-51. PubMed ID: 8622634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.